China Shineway Pharmaceutical Group Limited
CSWYY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $255,414 | $252,548 | $157,867 | $265,379 |
| - Cash | $6,140,153 | $5,888,776 | $5,026,265 | $4,205,722 |
| + Debt | $346,527 | $301,326 | $7,442 | $14,911 |
| Enterprise Value | -$5,538,212 | -$5,334,902 | -$4,860,956 | -$3,925,432 |
| Revenue | $3,778,043 | $4,516,538 | $3,950,636 | $3,223,550 |
| % Growth | -16.4% | 14.3% | 22.6% | – |
| Gross Profit | $2,831,749 | $3,394,119 | $2,938,314 | $2,410,336 |
| % Margin | 75% | 75.1% | 74.4% | 74.8% |
| EBITDA | $1,220,585 | $1,420,092 | $1,103,517 | $903,743 |
| % Margin | 32.3% | 31.4% | 27.9% | 28% |
| Net Income | $840,052 | $969,510 | $722,773 | $556,674 |
| % Margin | 22.2% | 21.5% | 18.3% | 17.3% |
| EPS Diluted | 444 | 513.4 | 384 | 296 |
| % Growth | -13.5% | 33.7% | 29.7% | – |
| Operating Cash Flow | $963,135 | $932,635 | $1,109,676 | $703,150 |
| Capital Expenditures | -$140,112 | -$144,325 | -$129,463 | -$93,633 |
| Free Cash Flow | $823,023 | $788,310 | $980,213 | $609,517 |